Literature DB >> 2981923

Induction of cAMP-dependent protein kinase I during human monocyte differentiation.

G D Wenger, M S O'Dorisio.   

Abstract

Differentiation of human peripheral blood monocytes into macrophages was accompanied by induction of the regulatory subunit of cAMP-dependent protein kinase I as determined by photoaffinity labeling of cytosol proteins with 8-N3-[32P]cAMP and DEAE-Sephacel chromatography. The appearance of cAMP-dependent protein kinase I in macrophages was not due to translocation from the particulate fraction of monocytes. The regulatory subunit of cAMP-dependent protein kinase II was present in both monocytes and in vitro-differentiated macrophages. Protein kinase I in macrophages demonstrated higher affinity for 8-N3-cAMP (KD = 0.7 nM) than did protein kinase II from either monocytes (KD = 14.5 nM) or macrophages (KD = 4.9 nM). These studies demonstrate induction of the regulatory subunit of cAMP-dependent protein kinase I during the differentiation of a normal human cell and support the hypothesis that cAMP may regulate some stages of differentiation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981923

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  2 in total

1.  Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity.

Authors:  Sadia Saeed; Jessica Quintin; Hindrik H D Kerstens; Nagesha A Rao; Ali Aghajanirefah; Filomena Matarese; Shih-Chin Cheng; Jacqueline Ratter; Kim Berentsen; Martijn A van der Ent; Nilofar Sharifi; Eva M Janssen-Megens; Menno Ter Huurne; Amit Mandoli; Tom van Schaik; Aylwin Ng; Frances Burden; Kate Downes; Mattia Frontini; Vinod Kumar; Evangelos J Giamarellos-Bourboulis; Willem H Ouwehand; Jos W M van der Meer; Leo A B Joosten; Cisca Wijmenga; Joost H A Martens; Ramnik J Xavier; Colin Logie; Mihai G Netea; Hendrik G Stunnenberg
Journal:  Science       Date:  2014-09-26       Impact factor: 47.728

2.  Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates.

Authors:  Marnix Lameijer; Tina Binderup; Mandy M T van Leent; Max L Senders; Francois Fay; Joost Malkus; Brenda L Sanchez-Gaytan; Abraham J P Teunissen; Nicolas Karakatsanis; Philip Robson; Xianxiao Zhou; Yuxiang Ye; Gregory Wojtkiewicz; Jun Tang; Tom T P Seijkens; Jeffrey Kroon; Erik S G Stroes; Andreas Kjaer; Jordi Ochando; Thomas Reiner; Carlos Pérez-Medina; Claudia Calcagno; Edward A Fisher; Bin Zhang; Ryan E Temel; Filip K Swirski; Matthias Nahrendorf; Zahi A Fayad; Esther Lutgens; Willem J M Mulder; Raphaël Duivenvoorden
Journal:  Nat Biomed Eng       Date:  2018-04-16       Impact factor: 25.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.